| ||
| ||
Diet Pill Maker Orexigen Sees Room for Three Rivals Minyanville.com The US can support multiple diet pills as an obesity epidemic created pent-up demand for such products, a company executive says. Orexigen rivals Arena Pharmaceuticals (ARNA) and Vivus (VVUS) appear to be close to receiving approvals that would make ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment